The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
02 2021
Historique:
received: 05 06 2020
revised: 01 12 2020
accepted: 10 12 2020
entrez: 28 12 2020
pubmed: 29 12 2020
medline: 14 9 2021
Statut: epublish

Résumé

Synovial sarcoma (SyS) is an aggressive mesenchymal malignancy invariably associated with the chromosomal translocation t(X:18; p11:q11), which results in the in-frame fusion of the BAF complex gene

Identifiants

pubmed: 33361335
pii: 4/2/e202000808
doi: 10.26508/lsa.202000808
pmc: PMC7768195
pii:
doi:

Substances chimiques

BANF1 protein, human 0
Chromatin 0
DNA-Binding Proteins 0
Histones 0
Multiprotein Complexes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020 Boulay et al.

Références

Elife. 2018 Nov 15;7:
pubmed: 30431433
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Cancer Cell. 2018 Mar 12;33(3):527-541.e8
pubmed: 29502955
Nat Genet. 2017 Feb;49(2):282-288
pubmed: 27941795
Genome Biol. 2014;15(12):550
pubmed: 25516281
PLoS One. 2009 Nov 19;4(11):e7904
pubmed: 19936258
Nature. 2007 Aug 2;448(7153):553-60
pubmed: 17603471
Cell. 2017 Nov 2;171(4):950-965.e28
pubmed: 29100075
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Rev Cancer. 2018 Jul;18(7):407-418
pubmed: 29692415
Cancer Res. 2014 Nov 15;74(22):6610-22
pubmed: 25261238
Cells. 2020 Jan 16;9(1):
pubmed: 31963307
Science. 2019 Jun 07;364(6444):952-955
pubmed: 31171691
Cancer Cell. 2007 Apr;11(4):375-88
pubmed: 17418413
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Cancer Cell. 2012 Jun 12;21(6):807-21
pubmed: 22698405
PLoS Comput Biol. 2013;9(8):e1003118
pubmed: 23950696
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nat Cell Biol. 2018 Dec;20(12):1410-1420
pubmed: 30397315
Cancer Discov. 2015 Feb;5(2):124-34
pubmed: 25614489
Sci Rep. 2016 Feb 24;6:22113
pubmed: 26905812
EMBO J. 1996 Oct 1;15(19):5370-82
pubmed: 8895581
Nat Genet. 2017 Feb;49(2):213-222
pubmed: 27941796
Front Oncol. 2019 Oct 18;9:1078
pubmed: 31681608
J Biol Chem. 2017 Feb 17;292(7):2893-2902
pubmed: 28073915
Cell Rep. 2016 Jan 12;14(2):332-46
pubmed: 26748712
Cancer Res. 2008 Apr 1;68(7):2176-85
pubmed: 18381423
Swiss Med Wkly. 2018 Dec 02;148:w14667
pubmed: 30506527
Genes Dev. 2019 Jan 1;33(1-2):4-5
pubmed: 30602437
Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3843-8
pubmed: 11274403
Bioinformatics. 2014 Jun 1;30(11):1618-9
pubmed: 24489365
Genes Dev. 2019 Jan 1;33(1-2):55-60
pubmed: 30567998
Bioessays. 2016 Sep;38(9):863-8
pubmed: 27374980
Annu Rev Pathol. 2020 Jan 24;15:211-234
pubmed: 31550983
Exp Hematol. 2017 Apr;48:12-31
pubmed: 28087428
Cancer Res. 2009 Mar 1;69(5):1776-81
pubmed: 19208848
Oncogene. 2012 May 3;31(18):2323-34
pubmed: 21996728
Cell Biochem Biophys. 2011 Jun;60(1-2):61-8
pubmed: 21468693
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Hum Mol Genet. 1999 Apr;8(4):585-91
pubmed: 10072425
Cell. 2013 Mar 28;153(1):71-85
pubmed: 23540691
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Cancer Cell. 2018 Jun 11;33(6):1128-1141.e7
pubmed: 29861296
Cancer Cell. 2012 Mar 20;21(3):333-47
pubmed: 22439931
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Cancer Cell. 2018 Aug 13;34(2):346-348
pubmed: 30107180
Cancer Res. 2007 Jan 1;67(1):398-407
pubmed: 17210723
Genes Dev. 1996 Sep 1;10(17):2117-30
pubmed: 8804307

Auteurs

Gaylor Boulay (G)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Luisa Cironi (L)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Swiss Cancer Center Leman, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Sara P Garcia (SP)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Shruthi Rengarajan (S)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Yu-Hang Xing (YH)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Lukuo Lee (L)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Mary E Awad (ME)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Beverly Naigles (B)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Sowmya Iyer (S)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Liliane C Broye (LC)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Swiss Cancer Center Leman, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Tugba Keskin (T)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Swiss Cancer Center Leman, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Alexandra Cauderay (A)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Carlo Fusco (C)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Swiss Cancer Center Leman, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Igor Letovanec (I)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Ivan Chebib (I)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Petur Gunnalugur Nielsen (PG)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Stéphane Tercier (S)

Department of Woman-Mother Child, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Stéphane Cherix (S)

Department of Orthopedics, Faculty of Biology and Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

Tu Nguyen-Ngoc (T)

Department of Oncology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Gregory Cote (G)

Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Edwin Choy (E)

Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

Paolo Provero (P)

Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milan, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.

Mario L Suvà (ML)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Miguel N Rivera (MN)

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Ivan Stamenkovic (I)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland Ivan.Stamenkovic@chuv.ch.
Swiss Cancer Center Leman, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Nicolò Riggi (N)

Institute of Pathology, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland nicolo.riggi@chuv.ch.
Swiss Cancer Center Leman, Centre Hospitalier Universitaire Vaudois, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH